Page last updated: 2024-10-31

methylphenidate and Alogia

methylphenidate has been researched along with Alogia in 1 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research Excerpts

ExcerptRelevanceReference
"A 76-year-old male with poststroke depression, seizure disorder, and global aphasia improved markedly when treated with methylphenidate."7.69Methylphenidate treatment of poststroke depression in a patient with global aphasia. ( Chaudhary, P; Masand, P, 1994)
"A 76-year-old male with poststroke depression, seizure disorder, and global aphasia improved markedly when treated with methylphenidate."3.69Methylphenidate treatment of poststroke depression in a patient with global aphasia. ( Chaudhary, P; Masand, P, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masand, P1
Chaudhary, P1

Other Studies

1 other study available for methylphenidate and Alogia

ArticleYear
Methylphenidate treatment of poststroke depression in a patient with global aphasia.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1994, Volume: 6, Issue:4

    Topics: Aged; Aphasia; Cerebrovascular Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Dru

1994